Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.

Learn about the impact of Alzheimer's family history on brain resilience and memory function. Your family tree may shape your ...

Claire Day, the Chief Mission and Program Strategy Officer for the Alzheimer's Association of Northern California & Northern ...

People with dementia sometimes get agitated and frustrated. New services provide a sort of Netflix for dementia, with videos ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Music therapy is proving to be a powerful adjunct treatment for a range of conditions, including Alzheimer’s disease, chronic ...